Literature DB >> 17761519

Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling.

Linlin Wang1, Thomas C Schulz, Eric S Sherrer, Derek S Dauphin, Soojung Shin, Angelique M Nelson, Carol B Ware, Mei Zhan, Chao-Zhong Song, Xiaoji Chen, Sandii N Brimble, Amanda McLean, Maria J Galeano, Elizabeth W Uhl, Kevin A D'Amour, Jonathan D Chesnut, Mahendra S Rao, C Anthony Blau, Allan J Robins.   

Abstract

Despite progress in developing defined conditions for human embryonic stem cell (hESC) cultures, little is known about the cell-surface receptors that are activated under conditions supportive of hESC self-renewal. A simultaneous interrogation of 42 receptor tyrosine kinases (RTKs) in hESCs following stimulation with mouse embryonic fibroblast (MEF) conditioned medium (CM) revealed rapid and prominent tyrosine phosphorylation of insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF1R); less prominent tyrosine phosphorylation of epidermal growth factor receptor (EGFR) family members, including ERBB2 and ERBB3; and trace phosphorylation of fibroblast growth factor receptors. Intense IGF1R and IR phosphorylation occurred in the absence of MEF conditioning (NCM) and was attributable to high concentrations of insulin in the proprietary KnockOut Serum Replacer (KSR). Inhibition of IGF1R using a blocking antibody or lentivirus-delivered shRNA reduced hESC self-renewal and promoted differentiation, while disruption of ERBB2 signaling with the selective inhibitor AG825 severely inhibited hESC proliferation and promoted apoptosis. A simple defined medium containing an IGF1 analog, heregulin-1beta (a ligand for ERBB2/ERBB3), fibroblast growth factor-2 (FGF2), and activin A supported long-term growth of multiple hESC lines. These studies identify previously unappreciated RTKs that support hESC proliferation and self-renewal, and provide a rationally designed medium for the growth and maintenance of pluripotent hESCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761519      PMCID: PMC2190616          DOI: 10.1182/blood-2007-03-082586

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  Common and distinct elements in cellular signaling via EGF and FGF receptors.

Authors:  Joseph Schlessinger
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

2.  Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers.

Authors:  Gillian M Beattie; Ana D Lopez; Nathan Bucay; Andrew Hinton; Meri T Firpo; Charles C King; Alberto Hayek
Journal:  Stem Cells       Date:  2005-04       Impact factor: 6.277

3.  Disruption of apical-basal polarity of human embryonic stem cells enhances hematoendothelial differentiation.

Authors:  Ana Krtolica; Olga Genbacev; Carmen Escobedo; Tamara Zdravkovic; Adam Nordstrom; Diana Vabuena; Aneel Nath; Carlos Simon; Keith Mostov; Susan J Fisher
Journal:  Stem Cells       Date:  2007-06-14       Impact factor: 6.277

4.  Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells.

Authors:  Alice Pébay; Raymond C B Wong; Stuart M Pitson; Ernst J Wolvetang; Gary S-L Peh; Adam Filipczyk; Karen L L Koh; Irene Tellis; Linh T V Nguyen; Martin F Pera
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

5.  Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells.

Authors:  Guolian Li; Eugene J Barrett; Hong Wang; Weidong Chai; Zhenqi Liu
Journal:  Endocrinology       Date:  2005-08-11       Impact factor: 4.736

6.  Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells.

Authors:  Petr Dvorak; Dana Dvorakova; Stanislava Koskova; Martina Vodinska; Miroslava Najvirtova; Daniel Krekac; Ales Hampl
Journal:  Stem Cells       Date:  2005-06-13       Impact factor: 6.277

7.  Derivation of human embryonic stem cells in defined conditions.

Authors:  Tenneille E Ludwig; Mark E Levenstein; Jeffrey M Jones; W Travis Berggren; Erika R Mitchen; Jennifer L Frane; Leann J Crandall; Christine A Daigh; Kevin R Conard; Marian S Piekarczyk; Rachel A Llanas; James A Thomson
Journal:  Nat Biotechnol       Date:  2006-01-01       Impact factor: 54.908

8.  Neurotrophins mediate human embryonic stem cell survival.

Authors:  April D Pyle; Leslie F Lock; Peter J Donovan
Journal:  Nat Biotechnol       Date:  2006-01-29       Impact factor: 54.908

9.  Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium.

Authors:  Chunhui Xu; Elen Rosler; Jianjie Jiang; Jane S Lebkowski; Joseph D Gold; Chris O'Sullivan; Karen Delavan-Boorsma; Michael Mok; Adrienne Bronstein; Melissa K Carpenter
Journal:  Stem Cells       Date:  2005-03       Impact factor: 6.277

10.  Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.

Authors:  Ludovic Vallier; Morgan Alexander; Roger A Pedersen
Journal:  J Cell Sci       Date:  2005-10-01       Impact factor: 5.285

View more
  148 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 2.  Extrinsic regulation of pluripotent stem cells.

Authors:  Martin F Pera; Patrick P L Tam
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 3.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

4.  Quantitative and semiquantitative immunoassay of growth factors and cytokines in the conditioned medium of STO and CF-1 mouse feeder cells.

Authors:  Neil C Talbot; Wendy O Sparks; Anne M Powell; Stanislaw Kahl; Thomas J Caperna
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-12-17       Impact factor: 2.416

5.  Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types.

Authors:  Tyrone Ryba; Ichiro Hiratani; Junjie Lu; Mari Itoh; Michael Kulik; Jinfeng Zhang; Thomas C Schulz; Allan J Robins; Stephen Dalton; David M Gilbert
Journal:  Genome Res       Date:  2010-04-29       Impact factor: 9.043

6.  Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules.

Authors:  Yue Xu; Xiuwen Zhu; Heung Sik Hahm; Wanguo Wei; Ergeng Hao; Alberto Hayek; Sheng Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-20       Impact factor: 11.205

7.  Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension.

Authors:  Debora Steiner; Hanita Khaner; Malkiel Cohen; Sharona Even-Ram; Yaniv Gil; Pavel Itsykson; Tikva Turetsky; Maria Idelson; Einat Aizenman; Rita Ram; Yael Berman-Zaken; Benjamin Reubinoff
Journal:  Nat Biotechnol       Date:  2010-03-28       Impact factor: 54.908

Review 8.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

9.  Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells.

Authors:  Robert Damoiseaux; Sean P Sherman; Jackelyn A Alva; Cory Peterson; April D Pyle
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

Review 10.  Signaling networks in human pluripotent stem cells.

Authors:  Stephen Dalton
Journal:  Curr Opin Cell Biol       Date:  2012-10-22       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.